Gonadotropin-releasing hormone analogs in the treatment of endometriomas

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


A limited number of small studies have assessed the efficacy of gonadotropin-releasing hormone agonists in the treatment of ovarian endometriomas. Most of these trials have not used quantitative measurements to evaluate the effects of therapy on disease resolution. The results available thus far suggest that nafarelin, buserelin, and histrelin offer modest degrees of efficacy, similar to that of danazol, in the management of patients with ovarian endometriotic cysts. Gonadotropin-releasing hormone agonists appear to be most efficacious when endometriomas are < 1 cm in size.

Original languageEnglish (US)
Pages (from-to)579-581
Number of pages3
JournalAmerican Journal of Obstetrics and Gynecology
Issue number2
StatePublished - Feb 1990


  • Buserelin
  • endometriomas
  • endometriosis
  • nafarelin
  • ovarian cysts

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Gonadotropin-releasing hormone analogs in the treatment of endometriomas'. Together they form a unique fingerprint.

Cite this